To include your compound in the COVID-19 Resource Center, submit it here.

Atara raises $150M in follow-on

Atara Biotherapeutics Inc. (NASDAQ:ATRA) raised $150 million on Feb. 28 through the sale

Read the full 138 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE